Circulating CD34-positive cell number is related to effective myocardial reperfusion in acute myocardial infarction treated with primary coronary angioplasty

Journal of Cardiovascular Medicine

Volumn 9, Issue 7, 2008, Pages 677-682

  Mariani, Matteo ^a,b   De Servi, Stefano ^a   Chianese, Rosa ^a,b   Beria, Gabriella ^a   Gatti, Arianna ^a,b   Poletti, Fabrizio ^a   Del Rosso, Gianfranco ^a   Fetiveau, Raffaela ^a   Poli, Arnaldo ^a   MacChi, Maurizio ^c   Brando, Bruno ^a,b  

^a Department of Cardiovascular Diseases ^*  (Italy)

^b Ospedale Civile di Legnano   (Italy)

^c AVIS   (Italy)

Author keywords

Acute myocardial infarction; Primary percutaneous coronary interventions; Stem cells

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CELL COUNT; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; AGE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; MIDDLE AGED; STENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIGENS, CD; ANTIGENS, CD34; CASE-CONTROL STUDIES; CORONARY CIRCULATION; GLYCOPROTEINS; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDES; RECOVERY OF FUNCTION; STENTS; VENTRICULAR FUNCTION, LEFT;

EID: 55249123666     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282f37d5a     Document Type: Article

References (30)

1. Masuda H, Asahara T. Postnatal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003; 58:390- 398.
2. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S,Burkoff D,Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function. Nat Med 2001; 7:430-436.
3. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardialischemia. Circulation 2003; 107:461-468.
4. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109:2972-2975.
5. Shintani S, Murohara T, Ikeda H, Ueno T, Hanma T, Katoh A, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103:2776-2781.
6. Quilici J, Banzet N, Paule P, Meynard JB, Mutin M, Bonnet JL, et al. Circulating endothelial cells count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation 2004; 110:1586-1591.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007.
8. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Circulation 2005; 111:2981-2987.
9. van't Hof AWJ, Liem A, Suryapranata H. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998; 97:2302-2306.
10. Poli A, Fetiveau R, Vandoni P, del Rasso G, D'urbano M, Seveso G, et al. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty. Real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 2002; 106:313-318.
11. Schiller NB, Shah PM, CrawfordM,DeMariaA,DevereuxR,Feigenbaum H, et al. Recommendation for quantification of left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Sub-committee on Quantification of Two-dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358- 367.
12. Mariani M, Fetiveau R, Rossetti E, Poli A, Poletti F, Vandoni P, et al. Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J 2006; 27:2511-2515.
13. pos cells. J Biol Regul Homeost Agents 2003; 17:254-260.
14. + hematopoietic stem and progenitor cells. Cytometry 1998; 34:128-142.
15. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701- 705.
16. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004; 364:183-192.
17. + hematopoietic stem cells. Ann N Y Acad Sci 2003; 996:141-151.
18. + progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004; 44:458-463.
19. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
20. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45:1449-1457.
21. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2005; 25:296-301.
22. + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004; 110:3213-3220.
23. Wojakowski W, Tendera, Zebzda A, Michalowska A, Majka M, Kucia M, et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 2006; 27:283-289.
24. Gibson CM. Has my patient achieved adequate myocardial reperfusion? Circulation 2003; 108:504-507.
25. Gibson CM, Schömig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation 2004; 109:3096-3105.
26. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovanni S, et al. Mobilization of bone-marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005; 26:1196-1204.
27. Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol 2004; 44:464-466.
28. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Hoematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428:664-668.
29. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer myocardial infarction: the BOOST randomized control. Lancet 2004; 364:141-148.
30. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. J Am Coll Cardiol 2004; 44:1690-1699.